Erasca

ERAS · NASDAQ

$14.62+$1.00 (+7.34%)TodayMarket closed ·
Prev close $13.62

Who owns ERAS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 48.8% of ERAS’s shares.

  • Frazier Life Sciences Management, L.P.7.3%
  • T. Rowe Price Investment Management, Inc.6.2%
  • Lim (Jonathan E)5.7%
  • RTW Investments L.P.5.2%
  • Next 6 largest institutions24.4%
  • All other shareholders51.2%
Top institutional holders of ERAS
HolderShares% of shares
Frazier Life Sciences Management, L.P.24.98M7.30%
T. Rowe Price Investment Management, Inc.21.19M6.19%
Lim (Jonathan E)19.46M5.68%
RTW Investments L.P.17.95M5.24%
VR Adviser, LLC17.89M5.23%
BlackRock Institutional Trust Company, N.A.16.02M4.68%
City Hill Ventures, LLC12.90M3.77%
Novartis Pharma AG12.31M3.60%
State Street Investment Management (US)12.18M3.56%
Logos Global Management LP12.15M3.55%

Largest mutual fund holders

Top mutual fund holders of ERAS
HolderShares% of shares
Vanguard Total Stock Market Index Fund9.81M2.87%
State Street SPDR S&P Biotech ETF7.85M2.29%
iShares Russell 2000 ETF5.68M1.66%
T. Rowe Price Small Cap Stock Fund3.28M0.96%
Vanguard Extended Market Index Fund3.12M0.91%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of ERAS in the last 6 months.

Latest ERAS insider transactions
InsiderTypeSharesValue
Fuchs Charles S.Award1.30M—

Short interest

Settled Sep 30, 2026

Shares short
35.34M
Days to cover
6.87
% of shares outstanding
10.33%
Average daily volume
5.14M
Change since last report
+7.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.